Premarket Stock Movers — September 17, 2026: Why AEMD, MEDS, DAIC, TURB & KXIN Are Surging

AEMD — Aethlon Medical (+454.5%)

Aethlon Medical is the most explosive premarket mover this morning, trading at $7.93 — up 454.5% from its prior close — on a staggering 39.3 million shares of premarket volume against a 20-day average of just 3.2 million. That's roughly 12× its normal daily activity before the opening bell has even rung.

Why it's moving: Aethlon has announced a merger with North Immunology, a deal reported to be valued at $180 million and centered on a new antibody targeting skin disease (eczema), according to headlines from TipRanks, Stock Titan, and GuruFocus this morning. The transaction would make Aethlon a minority owner in North Immunology. M&A announcements — especially ones that attach a micro-cap shell to a larger therapeutic asset — routinely produce violent price spikes like this.

The technical picture heading into this morning was deeply depressed: RSI of 35, a bearish moving-average stack, sitting 75.1% below its 52-week high, and a StockSetups conviction score of just 4/100 (grade D). In other words, there was no technical setup driving this — the merger headline alone is doing all the work.

The float is large (99.3% of shares outstanding are freely trading) and short interest is modest at 461,661 shares with just 0.1 days to cover (meaning short sellers could exit in a fraction of a trading day), so a mechanical short squeeze is not a meaningful amplifier here. The squeeze score of 40/100 and GuruFocus's note of market skepticism on price-to-sales are worth keeping in mind. With a market cap of only $1.0 million before this move, any dilution or deal complication could reverse gains quickly.

MEDS — DataMeds AI, Inc. (+321.0%)

DataMeds AI is surging 321.0% to $6.82 in premarket trading on 2.8 million shares — slightly below its 20-day average of 3.9 million, which reflects how early and concentrated this premarket reaction still is.

Why it's moving: According to Advfn, Quiver Quantitative, and StocksToTrade (all dated September 16), DataMeds AI has completed a $1.5 million acquisition of Helomics, an oncology laboratory, expanding the company's push into cancer diagnostics. The deal was confirmed on September 16, and the premarket continuation today reflects traders carrying that momentum forward. MEDS actually appeared as a mover in yesterday's premarket recap as well — this is a multi-session story.

One notable caution: the September 16 8-K SEC filing is flagged as dilution-bearing and bearish. That means additional shares may have been issued to fund or settle the Helomics deal, which can weigh on price over time even if the headline is positive. The free float is 100%, and short interest is thin at 173,986 shares (0.2 days to cover), so short covering is not a driver here.

Technically, MEDS carried a conviction score of 100/100 (grade A+) and an ADX of 39 into this move — the strongest technical read of this morning's five movers — with a gap of 3.4% already baked into the prior-session chart. RSI was 49, suggesting the stock was not overbought before the spike. Reddit's r/all-stocks had 26 mentions of MEDS, ranking it #16 — a modest but real retail attention signal.

DAIC — CID Holdco, Inc. (+99.5%)

CID Holdco is doubling premarket, up 99.5% to $4.01 on 25.0 million shares — well above its 20-day average of 17.3 million. This is the largest market cap of the morning's five movers at $60.8 million, and it's arriving in premarket on the back of a busy news cycle.

Why it's moving: Headlines from Minichart and TradingView on September 16 report that CID Holdco plans to acquire Envoy Technologies in a $65 million all-stock deal. The company also reportedly secured a bridge note and settled $1.09 million in debt as part of a broader restructuring. Benzinga flagged the stock surging 72.64% in after-hours last night, suggesting the move is carrying into this morning's premarket.

However, the risk picture is layered. CID Holdco has multiple bearish SEC filings on record: two delisting-risk 8-Ks (August 18 and September 1), a late 10-Q filing, and a September 16 8-K flagged for dilution — all consistent with a company under financial stress. StocksToTrade's own September 17 headlines describe mounting losses and dilution risk even as the stock surges. The prior-day candlestick pattern was three black crows — a classically bearish three-candle formation — and the stock sits 65.1% below its 52-week high.

What the technical scan does show in its favor: a bullish MA stack, RS rating of 97, technical rank of 92, and conviction score of 76/100 (grade A) — the highest conviction read of the morning's group. The squeeze score is low at 9/100, with 0.0 days to cover, so short-covering is not a factor. This move is driven by the deal and restructuring narrative, not momentum or a squeeze.

TURB — Turbo Energy, S.A. (+83.6%)

Turbo Energy is up 83.6% to $1.64 premarket on an extraordinary 35.7 million shares — versus a 20-day average of just 130,338. That's approximately 274× normal daily volume before the market opens. Volume spikes of this magnitude in micro-caps, especially with no news on file, are a major red flag as well as a momentum signal.

Why it's moving: There are no headlines or SEC filings in this morning's data to explain the catalyst. With no confirmed news driver, the move appears to be momentum- and technically-driven, likely amplified by the extremely low baseline liquidity. When a stock that normally trades 130,000 shares suddenly prints 35 million premarket, it frequently reflects a viral social-media mention, a speculative rumor, or simply traders front-running a perceived squeeze — none of which is verifiable from available data.

The technical setup heading into this morning was bearish: RSI of 28 (oversold territory), a bearish MA stack, conviction score of 28/100 (grade D), and sitting 92.8% below its 52-week high — essentially a stock in a prolonged downtrend. The squeeze score is 47/100 with 2.6 days to cover — the highest short-covering pressure of this morning's group. "Days to cover" measures how many days of average trading volume it would take for all short sellers to buy back their borrowed shares; at 2.6 days, any buying surge can force short sellers to cover at rapidly rising prices, accelerating the move. That mechanical dynamic, combined with thin liquidity, may explain the extreme move even without a visible catalyst.

This is exactly the kind of low-float, no-news, extreme-volume premarket spike that can reverse as fast as it appeared once regular-session liquidity returns.

KXIN — Kaixin Holdings (+48.4%)

Kaixin Holdings is up 48.4% to $1.67 premarket on 17.7 million shares — roughly 17× its 20-day average of 1.06 million. The China-based used-car platform is the fifth-biggest mover this morning, and it has a clearer fundamental catalyst than most.

Why it's moving: Kaixin reported first-half 2026 earnings that showed a significant revenue surge alongside a sharply reduced net loss, according to TipRanks and Stock Titan (September 16). Benzinga noted the stock soared 138% in after-hours on the news, citing a 600% revenue jump year-over-year. The company filed a 6-K (foreign private issuer report) with the SEC on September 16, confirming a real filing event underpinning the move. Premarket gains of 48.4% represent a partial cooling from those after-hours highs.

The technical picture is a study in extremes: RSI of just 17 (deeply oversold), ADX of 55 (strong trend momentum — but trending down), and sitting 91.8% below its 52-week high. The gap into this morning's premarket is already +5.8% above the prior close, and the conviction score is 8/100 (grade D). An important counterweight in the headlines: Stock Titan flags going-concern doubts in the same earnings report — meaning Kaixin's auditors have raised questions about the company's ability to continue operating, which is a serious risk disclosure that often limits how far a relief rally can run.

Short interest is 391,562 shares with 0.2 days to cover and a squeeze score of 15/100 — not a squeeze story. This is a pure earnings-reaction move in a deeply distressed, high-risk micro-cap.

The bottom line

This morning's five premarket movers — AEMD, MEDS, DAIC, TURB, and KXIN — illustrate how quickly micro-cap and small-cap stocks can move before the opening bell, and how different the catalysts can be: mergers, acquisitions, earnings beats, restructuring deals, and — in TURB's case — no visible catalyst at all.

A few honest reminders before the 9:30 AM open:

• Premarket volume is thin. Prices can be far more volatile and spreads far wider than in regular hours. The moves you see now may not hold once institutional and retail liquidity floods in at the open.
• Big premarket gainers frequently give back gains. Chasing a stock that is already up 100%–450% before the bell is among the highest-risk trades a trader can make. Many of these names are sitting deep in downtrends, carry dilution risk, or have going-concern disclosures.
• Patterns and squeezes fail. Even the stocks with strong conviction scores (MEDS at 100/100, DAIC at 76/100) carry structural risks documented in their own SEC filings.
• Manage risk and do your own research. Nothing here is a recommendation to buy or sell any security.

StockSetups scans the full ~12,300-stock US universe every premarket morning — detecting patterns, scoring setups, and flagging the names that are moving before the open. Check back after today's close for the full after-close recap of how these names traded in the regular session.